Hedge Fund Stocks Based on Pattern Recognition: Returns up to 41.85% in 14 Days

Hedge Fund Stocks

This Hedge Fund Stocks Package is designed for investors and analysts who need predictions of the best-performing stocks according to I Know First’s stock market algorithm. It includes 20 stocks with bullish and bearish signals and indicates the best stocks to long and short based on artificial intelligence trading strategies:

  • Top 10 Hedge Fund stocks for the long position
  • Top 10 Hedge Fund stocks for the short position

hedgefunds
Package Name: Hedge Fund Stocks
Recommended Positions: Long
Forecast Length: 14 Days (6/21/22 – 7/5/22)
I Know First Average: 6.53%
Hedge Fund Stocks
Hedge Fund Stocks chart

For this 14 Days forecast the algorithm had successfully predicted 6 out of 10 movements. BLUE was the top performing prediction with a return of 41.85%. Further notable returns came from ESTC and SQ at 15.83% and 14.05%, respectively. The overall average return in this Hedge Fund Stocks package was 6.53%, providing investors with a 2.27% premium over the S&P 500’s return of 4.26% during the same period.

bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company’s clinical programs in severe genetic diseases include its LentiGlobin product candidate to treat transfusion-dependent b-thalassemia (TDT) and to treat severe sickle cell disease (SCD) and its Lenti-D product candidate to treat cerebral adrenoleukodystrophy (CALD). Its programs in oncology are built upon its lentiviral gene delivery and T cell engineering, with a focus on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies. bb2121, its lead product candidate in oncology, is a CAR T cell product candidate for the treatment of multiple myeloma. It also has discovery research programs utilizing megaTALs/homing endonuclease gene editing technologies for use across its pipeline.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.